NCT03124875View on ClinicalTrials.gov

PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

August 8, 2019

Study Completion Date

January 5, 2021

Conditions
Critical Limb IschemiaChronic Limb-Threatening Ischemia
Interventions
DEVICE

LimFlow System

Creation of an AV fistula in below-the-knee vasculature for the treatment of critical limb ischemia.

Trial Locations (7)

10029

Mount Sinai Health System, New York

20010

Medstar Washington Hospital Center, Washington D.C.

29203

Palmetto Health, Columbia

44106

University Hospitals Cleveland Medical Center, Cleveland

49519

Metro Health, University of Michigan, Wyoming

87102

New Mexico Heart Institute, Albuquerque

96817

Kaiser Permanente, Honolulu

Sponsors

Lead Sponsor

LimFlow, Inc.
All Listed Sponsors
lead

LimFlow, Inc.

INDUSTRY

NCT03124875 - PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System | Biotech Hunter | Biotech Hunter